APPLICATIONS PUBLISHED 4 FEBRUARY 2004
Published: 1-Aug-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
Incyte San Diego 1385465*
Oncolytic virus therapy
Wellstat Biologics 1385466*
Use of oligomeric proanthrocyanidins
Cognis France 1385473*
Immunity adjuvant containing a complexed metal cation and vaccine containing same
Societe d'Exploitation de Produits pour les Industries Chimiques 1385475*
Methods of diagnosing and treating small intestinal bacteria overgrowth (SIBO) and SIBO-related conditions
Cedars-Sinai Medical Centre 1385476*
Antimicrobial polyurethane films
Milliken & Co 1383477*
Method for applying an active ingredient to a substrate, compsns for said method, container containing a compsn and use of said compsns
Vesifact 1385478*
Liposome compsn for improved intracellular delivery of a therapeutic agent
Alza Corp 1385479*
Liposomes
Amersham Health 1385480*
Carbon nanotubes in structures and repair compsns
Eikos 1385481*
An effervescent solid compsn of matter
Medicarb 1385483*
Fast disintegrating meloxicam tablet
Boehringer Ingelheim International 1385483*
Compsns and methods of manufacture for oral dissolvable dosage forms
Cephalon 1385484*
Bioerodable poly(orthoesters) from dioxolane-based diketene acetals
AP Pharma 1385485*
A novel coating for a sustained release pharmaceutical compsn
Nostrum Pharmaceuticals 1385486*
Tablets with coloured patterns and preparation thereof
Phoqus Pharmaceuticals 1385487*
Methods and compsns for encapsulating active agents
President and Fellows of Harvard College 1385488*
Coated granules based on angiotensin-converting enzyme inhibitor
Ethypharm 1385489*
Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins
LTS Lohmann Therapie-Systeme 1385490*
Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis
Hans-Knoell-Institut fuer Naturstoff-Forschung 1385492*
Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
Gruenenthal 1385493*
Aerosol compsns containing formoterol and a steroid such as e.g. budesonide and fluticasone for delivery into the lungs
Dey LP 1385494*
Sulphonamides
SmithKline Beecham 1385495*
Use of compsns for treating rosacea
The Regents of the University of Michigan 1385496*
Methods of preventing or treating breast, prostate and/or cervical cancer with N,N-dimethylglycine
Foodscience Corp 1385497*
Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
Prometic Biosciences 1385498*
Fatty alcohols and fatty acid esters useful for treatment of inflammation
Yeda Research and Development 1385500*
Probucol monoesters and their use to increase plasma HDL cholesterol levels and improve HDL functionality
Atherogenics 1385501*
Method for the production of anhydrous, pharmaceutical formulations of xanthogenates
BioSphings 1385502*
The use of enantiomeric pure escitalopram
H Lundbeck 1385503*
Method of inhibiting adhesion formation
SmithKline Beecham 1385504*
Acne treatment
Zouboulis, Christos 1385505*
Acylated piperidine derivatives as melanocortin-4 receptor agonists
Merck 1385506*
Sulphonamides
SmithKline Beecham 1385507*
Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
Merck 1385508*
Method of treatment
SmithKline Beecham 1385509*
Prodigiosin compsns for the treatment of rheumatic arthritis
Korea Research Institute of Bioscience and Biotechnology 1385510*
Compsn comprising antifungal agents for treating vulvovaginits and vaginosis
McNeil-PPC 1385511*
Use of pyridoindole derivatives for preparing anticancer medicines
Sanofi-Synthelabo 1385512*
Pharmaceutical combinations based on pyridoindole derivatives and anticancer agents
Sanofi-Synthelabo 1385513*
Spiroindene and spiroindane compounds
Euro-Celtique 1385514*
Spiropyrazole compounds
Euro-Celtique 1385515*
The treatment of scarring and related conditions using PPAR-gamma activators
Arachnova Therapeutics 1385516*
Novel oral general anaesthetics and metabolically resistant anticonvulsants
University of Virginia Patent Foundation 1385517*
Benzimidazolone compounds
Euro-Celtique 1385518*
Compounds for treating inflammatory diseases
Boehringer Ingelheim Pharma 1385519*
Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
NPS Pharmaceuticals 1385520*
Pharmaceutical compsn containing PDE V inhibitors and surfactants
Merck 1385521*
Combination comprising a signal transduction inhibitor and an epithilone derivative
Novartis 1385522*
Adenosine A1 receptor antagonists for treating hypoxia-induced learning and memory impairment
Blanchette Rockefeller Neurosciences Institute 1385523*
Pyrazolopyrimidines as therapeutic agents
Abbott 1385524*
Targeted oxidative therapeutic formulation
Hofmann, Robert F 1385525*
3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
Allergan 1385526*
Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof
Stegram Pharmaceuticals 1385527*
Treatment of refractory tumours using epothilone derivatives
Bristol-Myers Squibb 1385529*
Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption
Mediplex Corp 1385530*
Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
Blanchette Rockefeller Neurosciences Institute 1385531*
Stimulation of osteogenesis using rank ligand fusion proteins
Barnes-Jewish Hospital 1385532*
Module of PD-1 interactions with its ligands
Wyeth 1385533*
